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ABSTRACT
Despite major decreases in cervical cancer incidence rates in the U.S. over the
past several decades, certain populations of women continue to be disproportionately
affected by it. One of these groups includes US Latina/Hispanic women who have the
highest cervical cancer incidence rates as compared to their racial/ethnic counterparts. To
improve detection and prevention in US Latina/Hispanic women, it is important to first
understand their current knowledge and health literacy with regard to cervical cancer.
This cross-sectional study examined perceived self-knowledge of cervical cancer
and cervical cancer functional health literacy in high-risk Hispanic women living in the
El Paso, Texas border region. Women were recruited via health clinic flyers and word-ofmouth from downtown El Paso neighborhoods and surrounding neighborhoods in the
border region. Data were collected through phone interviews using a questionnaire that
queried demographic and self-reported anthropometric measures, perceived selfknowledge of cervical cancer, vaccine history, and family history of disease. In addition,
a previously standardized health literacy assessment instrument, Cervical Cancer Literacy
Assessment Tool (C-CLAT), was administered. IRB approval was obtained from the
University of Texas at El Paso. Descriptive and inferential data analyses were conducted
with data from 85 women Latina/Hispanic women, ages 18-65, currently living in the El
Paso border region.
Descriptive analyses revealed that over 50% of women had never received printed
information regarding cervical cancer. Moreover, of those that said they knew what
cervical cancer was (75.3%), only about half were able to demonstrate basic knowledge
of the disease. As compared to women who did not know what cervical cancer was,
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cervical cancer health literacy scores were significantly higher among women that were able to
demonstrate cervical cancer knowledge. Surprisingly, functional health literacy was not
predicted by whether women had previously received any health information regarding the
disease, or whether women had previously received printed health information regarding the
disease.
We concluded that current education regarding cervical cancer among Latina/Hispanic
women in the El Paso border region may be both seriously lacking and inadequate when
provided. The practice of educating women about cervical cancer must be instituted in our
medical and public health communities; approaches for education must be expanded to include
media and content that are both culturally sensitive and easy to understand. Perhaps most
importantly, women must be educated on minimum prevention behaviors to ensure early disease
detection.
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1. INTRODUCTION
For over 15 years, ischemic heart disease and stroke were the leading causes of global
mortality (Ritchie & Roser, 2018). Findings from new research however have shown that in
some high-income and upper-middle class income countries, cancer is surpassing heart disease
as the leading global cause of death among adults aged 35-75 years (Dagenais, 2019), and cancer
is now becoming the leading cause of death in countries worldwide (Mahase, 2019). In the U.S.,
this trend of decreasing heart disease with increases in cancer is inconsistent across communities,
but has been found specifically among US Hispanic/Latinx 1 populations (Heron, 2017).
Cancer is currently the leading cause of death among US Hispanics. Although this
population tends to have lower cancer incidence and mortality rates as compared to non-Hispanic
whites for some of the most common cancers, US Hispanics tend to have higher incidence and
mortality rates for cancers associated with infectious agents (Miller, 2018). One of these cancers
is cervical cancer, it is also one of the most preventable ones. For several decades now, cervical
cancer incidence rates have declined in the United States due to the introduction and use of the
Pap exam. However, from 2011-2016, cervical cancer incidence rates were nearly 40% higher
among US Hispanic women as compared to non-Hispanic white women (American Cancer
Society [ACS], 2018). From 2012-2016, cervical cancer mortality rates were 26% higher as
compared to non-Hispanic whites.
These increased rates suggest gaps in screening and a need for education that leads to
individual behavior change. In doing so, it is essential to consider internal factors such as an
individual’s health knowledge and health literacy level that may be influencing screening

Having Hispanic or Latinx ethnicity refers to “a person of Cuban, Mexican, Puerto Rican, South or Central
American, or other Spanish culture or origin regardless of race” (US Census Bureau, 2018). For simplicity purposes,
the term Hispanic will be used hereafter to refer to both Hispanic or Latinx/o/a.
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practices. Researchers continues to investigate lack of cancer awareness and low levels of
knowledge in conjunction to health literacy as important barriers to access and health care which
may lead to inadequate screening rates (Chaka, 2018; Reynolds, 2004; Lindau et al., 2002).
Before comprehensive interventions can be developed, we need to understand gaps in
knowledge and the factors that may influence cervical cancer screening in higher risk female
populations such as those living along the US-Mexico border. Women living in that particular
geographic location experience greater cervical cancer screening disparities as compared to
women living in other US regions (Fernandez, 2009). Furthermore, women living along the USMexico border face different health risks and challenges and barriers to care compared to women
in the US general population (U.S. Department of Health and Human Services, Health Resources
and Services Administration, Maternal and Child Health Bureau, 2009).
1.1 Cancer Health Disparities Among US Hispanics
Health disparities afflict minority racial/ethnic and low-income groups such as US
Hispanics. Hundreds of studies conducted over the past 40 years have shown that people of
Hispanic descent have specific health disparities (Velasco-Mondragon, 2016) which encompass
chronic diseases such as diabetes mellitus, stomach cancer, liver cancer, and namely cervical
cancer (Vega, 2009). They play a pronounced role in the increasing disproportional rates of
cervical cancer among US Hispanic women.
In the US, Hispanic health and health disparities are a focus of many modern initiatives in
medicine. There are many reasons for this responsiveness. First, Hispanic populations are
currently the largest ethnic minority residing in the US (Lopez, 2013). According to data from
the United States Census Bureau in 2017, approximately 18.3% of the total population and its
territories self-identified as Hispanic. There is a high concentration of Hispanics in the Western
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and Southern parts of the US with more than half residing in three states including California
(27%); Texas (19%); and Florida (9%) (ACS, 2018). Additionally, Hispanic populations are one
of the top three fastest growing sub-populations in the United States. By 2060, the total US
population and its territories are expected to have approximately 29% Hispanic peoples (Colby,
2015).
A second reason for responsiveness to increasing rates of cancer among Hispanic
populations is their age. Hispanic populations are the youngest racial/ethnic group living in the
US. In 2015, Hispanics had a median age of 27 years while the US general population had a
median age of 37 years and non-Hispanic whites had a median age of 42 years (VelascoMondragon, 2016). As this population transitions to older age in the coming years, the
demographic of Hispanics aged 65 and older will increase 134% between 2012 and 2050 in
comparison to only 58.4% among non-Hispanic whites (Ortman, 2014). Since cancer is a
chronic disease and more often occurs in older adults, this will have important implications for
the increased economic and cancer burden of this population as well as the entire nation as a
whole (Erikson, 2007). Increases in cancer diagnosis will also have an impact on cancer care,
especially for certain minorities that experience higher cancer incidence rates and lower cancer
survival rates as compared to non-Hispanic whites (Smith, 2009). Cancer care treatment
regimens will also need to be inclusive of older adults and minorities such as Hispanics who
have been particularly vulnerable to suboptimal cancer care due to the under-representation they
have in cancer clinical trials, and the disparities in cancer treatment they experience (Smith,
2009; Gross, 2008).
Third, Hispanics, especially women, rank among the highest in prevalence for certain
cancer risk factors including obesity and type 2 diabetes (Sauer, 2017). A prior study conducted
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among US adults aged 50 and older approximated 20% of cancer deaths due to obesity in women
and 14% of obesity-related deaths occur in men (Calle, 2003). Over the last 25 years, more
research has accumulated showing how physiological characteristics of obesity including
increased IGF-1 (Weroha, 2012), chronic low-level inflammation (Schacter, 2002), and
increased estrogen production (Clemons, 2001), contribute to increased cancer risk. Current
studies continue to add to the evidence of links between obesity and 13 different types of cancers
that include gastrointestinal and reproductive system cancers.
According to the American Cancer Society, in 2015-2016, obesity prevalence was 51%
among Hispanic adult females and 43% among Hispanic adult males as compared to 38% among
non-Hispanic whites of either sex. Although the association of type 2 diabetes and cancer risk is
not yet fully understood, there is growing evidence that type 2 diabetes also increases cancer risk
for several types of cancers which may include liver, pancreas, uterine, breast, colon, bladder,
and perhaps ovarian cancer (Wang, 2017).
Lastly, Hispanics are particularly vulnerable to an array of health disparities. These often
result from the broad range of factors attributed to the social determinants of health (SDOH) that
may include educational level, socioeconomic status, access to health care, employment, and the
built-environment (Askim-Lovseth, 2010). For instance, as compared to non-Hispanic whites,
US Hispanics are four times more likely to not have finished high school, are twice as likely to
live below the poverty line, and are 20 times less likely to speak English (Velasco-Mondragon,
2016). Moreover, when compared to other ethnic groups, US Hispanics have lower rates of
health insurance, have less access to health services, and are less likely to use preventive services
(Velasco-Mondragon, 2016; Vega, 2009). Of key importance is insurance coverage because it is
a determinant of access to health care services. Prior population-based studies have determined
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that cancer patients without private insurance are more likely to be diagnosed at more advanced
stages of the disease, are less likely to receive treatment, and have worse survivorship
experiences (Colby, 2018; Pan, 2017). Moreover, not having health insurance and having limited
access to health care can also lead to under recognition of disease, and underestimates of selfreported disease prevalence (Dominguez, 2015). Of special interest are Hispanic women because
as a group, they endure adverse social and health conditions and often times lack access to health
care services (Paz, 2016). This is especially true among Hispanic women living along the USMexico border in El Paso, TX.
1.2 Cancer Risk Among Females Living in the U.S. – Mexico Border Region
El Paso, TX, is a border city that is geographically located on the western most tip of
Texas. It occupies over 1,000 square miles and borders both New Mexico and Ciudad Juarez,
Chihuahua, Mexico. According to demographic data provided by Healthy Paso del Norte, El
Paso TX currently has a population size of approximately 850,000 including 49.2% males and
50.8% females. The majority (88%) of the population is of Hispanic/Latinx ethnicity and the
population is relatively young. Eighty-eight percent of the Hispanic population is under the age
of 65 years. The median household income varies by race/ethnicity with Hispanics averaging
$41,737, ranking lower than the rest of Texas (U.S. Census Bureau, 2018). The educational
attainment of the population for adults 25 years and older is varied, for example only 76.9% have
a high school degree or higher; and only 22.2% have bachelor’s degree or higher. Approximately
21.7% of families currently live below the poverty level. In addition, there are marked disparities
concerning health and access to health care services in El Paso. Approximately 32.5% of adults
do not have health insurance and 22.8% of adults are unable to afford to see a doctor (Healthy
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Paso Del Norte Far West Texas, Southern New Mexico, Ciudad Juarez, 2019). Perhaps of
greatest concern is the increasing incidence of cervical cancer in El Paso, TX.
1.3 Cervical Cancer Incidence and Mortality Rates
From 2011-2015, US Hispanic women had the highest cervical cancer incidence rates,
9.6%, as compared to their racial/ethnic counterparts which included non-Hispanic White, nonHispanic Black, Asian and Pacific Islander, and American Indian and Alaskan Native; rates were
7.1%, 9.2%, 6.0%, and 9.2% respectively (ACS, 2018). Additionally, regionally specific
cervical cancer incidence rates show that pockets of U.S. women are at significantly higher risk
as compared to women in other regions (Horner, 2011). Hispanic women living in the Midwest
(Mississippi Valley and southern Appalachia) and the Texas-Mexico border had among the
highest cervical cancer incidence rates in the nation (15.3 per 100,000) and similar mortality
rates (American Cancer Society [ACS], 2015; Horner, 2011). Yet data from another study
revealed that for women living along border communities the cervical cancer incidence rate is
actually higher (16.6 per 100,000) (Molokwu, 2014).
It is important to note that cervical cancer incidence and mortality rates declined by 3.9%
and 2.3%, respectively, between 2003 and 2012 among US Hispanic women and are currently
estimated to be 9.6% and 2.6% but are still considered unacceptably high (ACS, 2015).
However, In El Paso, Texas, incidence rates are currently on the rise. Reported data from the
National Cancer Institute (NCI) during 2011-2015 showed that the cervical cancer incidence rate
was 10.3 per 100,000 females. Presently, according to the most recent NCI available data (2012
to 2016) cervical cancer incidence rates are at 10.8 cases per 100,000 Hispanic females and 8.8
cases per 100,000 non-Hispanic white females. When the El Paso overall cervical cancer
incidence rate, (10.5/100,000) is compared to the Texas state value (9.2/100,000), and the US
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national value (7.6/100,000 females), it is higher in El Paso amplifying the cervical cancer
disparity among minority women (Healthy Paso Del Norte Far West Texas, Southern New
Mexico, Ciudad Juarez, 2019).
1.4 Cancer Fundamentals in US Hispanic Populations
Cancer is a term used to describe a disease in which abnormal cells divide uncontrollably
and invade nearby tissues, which can lead to the growth of polyps; there are over 100 different
types of cancers (NCI, 2015). These cancers are normally named for the organs or tissues where
the cancer forms, or described by the type of cell that formed them (NCI, 2017). Infection-related
cancers are a special class of cancer and result from infectious agents that can cause cancers of
the liver, stomach, and uterine cervix (ACS, 2018).
In the United States general population, the four most common cancers include lung,
colorectal, breast and prostate (ACS, 2015). Interestingly, incidence rates of the four most
common cancers are lower in US Hispanics in comparison to higher incidence rates among nonHispanic whites (NHWs), but for some acculturated Hispanics the rates approach or surpass
those of NHWs (ACS, 2018). Conversely, incidence and rates of infection-related cancers
(stomach, liver, cervix) and gallbladder are higher among Hispanics than in NHWs, similar to
the cancer burden in economically developing countries such as Latin America (Torre, 2015).
Mortality rates of infection-related cancers are also higher among US Hispanics relative to
NHWs, especially for first generation immigrants for stomach and cervical cancers.
Cancer of the uterine cervix, also known as cervical cancer, begins in the cervix. The
cervix is conical shape and is located in between the vagina (birth canal) and the upper part of
the uterus (womb where baby grows) (Centers for Disease Control and Prevention [CDC], 2019).
In non-pregnant fertile women, the cervix measures approximately 3cm in length and 2.5cm in
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diameter (National Center for Biotechnology Information [NCBI], 2014). The lower one third of
the cervix is known as the ectocervix and is covered with flat, thin cells called squamous cells.
The upper two thirds of the cervix is known as the endocervix and is made up of columnar cells.
The area where the ectocervix and the endocervix join is known as the “transformation zone” (TZone) and is where most precancerous or abnormal cells develop (NCBI, 2014). The majority of
cervical cancers (80-90%) are squamous cell cancers while the remaining cases are
adenocarcinomics (CDC, 2019). One prevalent source of these cervical cell abnormalities is long
lasting infection with the human papillomavirus (HPV).
1.5 Cancer Risk and HPV
HPV is the most common sexually transmitted infection (STI) in the US. Seventy-nine
million Americans are currently infected with the HPV virus (CDC, 2018). It is acquired after
initiating sexual activity and does not usually present symptoms, making it difficult to detect and
easy to transmit. Adding to the complexity is the fact that there are more than 200 related HPV
types and more than 40 that can be spread through direct sexual contact (NIH, 2019). As a result,
HPV types are categorized into two groups, low-risk HPVs and high-risk HPVs (CDC, 2018).
Low-risk HPVs include types that can cause warts. The most common ones include HPV6 and
HPV11 which account for about 90% of genital warts (CDC, 2015). While low-risk HPVs cause
almost no disease, high-risk HPVs (oncogenic) can cause up to at least 6 different types of
cancers. These include cancers of the vulva, vagina, penis, anus, oropharynx and notably, cervix
(CDC, 2018). Two of the most common high-risk types, HPV16 and HPV18, are responsible for
70% of cervical cancers and pre-cancerous cervical lesions (World Health Organization [WHO],
2019). In most cases, however, HPV infection (regardless of type) is short lived since the body’s
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immune system is able to spontaneously eliminate the infection in less than two years (NCBI,
2014). As a result of this phenomenon, very few HPV infections lead to cervical cancer.
When persistent infection by high-risk HPV types occurs, changes in cells of the cervix
can lead to pre-cancer cells. These cells are not cancerous, and they do not cause symptoms. In
most cases, pre-cancer cells change back to normal on their own and if they do not, they can be
treated. If the pre-cancer cells are left untreated they can turn into cancer (ACS, 2016).
Moreover, if pre-cancer cells are not identified at all over the course of time, it too can lead to
cervical cancer. In these cases, symptoms may manifest because the cancer will be at a more
advanced stage. These symptoms can include abnormal vaginal bleeding or discharge, pelvic
pain or pressure, frequent urination and/or constipation, abdominal or back pain, itching,
burning, pain or tenderness of the vulva, and changes in the vulva color or skin, such as rash,
sores, or warts (CDC, 2016).
Though HPV research is still ongoing, the association between HPV infection and the
development of cervical cancer was demonstrated as early as the 1980s by German virologist
Harald Zur Hausen (Bosch, 2002). In the years that followed, largely from observational studies,
more evidence accumulated between the link of several HPV types and the development of other
gynecological cancers. In fact, it now widely recognized that almost all cervical cancers are
caused by HPV (CDC, 2019).
1.6 Other Cancer Risk Factors Among Women
In addition to long term infection with HPV, there are other risk factors that can put a
woman at an increased risk for developing cervical cancer. These include having multiple sex
partners, early age at first intercourse, being a tobacco smoker, having an autoimmune disease
such as HIV/AIDS, using birth control pills for five or more years, and having given birth to
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three or more children (CDC, 2019; Reynolds, 2004). Those at highest risk for cervical cancer
include women between the ages of 40 to 59 and women who have not been screened at all or
who have been inadequately screened (Flores, 2013).
1.7 Preventing Cervical Cancer
While some risk factors such as age are not modifiable, there are certain behavioral
practices than can be initiated and/or modified in order to reduce the risk of developing cervical
cancer, a disease that is highly preventable. Perhaps most importantly, for women with access to
knowledge and healthcare, specific behavioral practices including vaccinating against HPV and
regular screening for abnormal cell changes in the cervix, can almost completely prevent cervical
cancer, and/or improve survivorship if detected, through effective treatment.
Recognizing the critical importance of supporting changes in behavioral practices, the
World Health Organization (WHO) recommends a comprehensive multidisciplinary approach.
The comprehensive approach focuses on interventions across a person’s life span that involve
primary, secondary and tertiary levels of prevention and intervention (WHO, 2014). The
approach also centers on integrating health education at every level of prevention to improve
awareness and build knowledge of cervical cancer and screening for improved cervical cancer
outcomes. Past literature has shown that appropriate health education interventions among
diverse populations can increase screening uptake and thus reduce fatalities from cervical cancer
(Abiodun et al, 2014).
1.8 Primary Prevention of Cervical Cancer: HPV Vaccination
The first level of prevention begins with primary prevention. This entails receiving an
HPV vaccination against infection from certain types or strains of HPV. Presently, there are three
HPV vaccines marketed throughout the world. These include a bivalent, a quadrivalent, and a
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nonvalent vaccine (WHO, 2017). As the names suggest, the vaccines vary in the types and
number of strains they protect against. All three types of vaccines have proven to be efficacious
in preventing HPV infection with high-risk types and in some cases, low-risk types (Petrosky,
2015); importantly, these are available in several countries.
The quadrivalent HPV vaccine was first introduced in the US in June of 2006. It was
licensed by Merck & Co. under the name of Gardasil and approved for use by the US Food and
Drug Administration (FDA). It protects against four types of HPV-6, 11, 16, and 18 (KFF,
2018). In December 2009, the FDA approved the bivalent vaccine known as Cervarix and
licensed by GlaxoSmithKline which only protects against the two common HPV high-risk types
(Petrosky, 2015). In 2014, the nonvalent vaccine (next generation Gardasil) was approved by the
FDA and is currently the only vaccine available in the US (NCI, 2019). This vaccine known as
Gardasil 9, protects against 9 types of HPV; the four from the first-generation Gardasil vaccine
in addition to five other HPV types: 31, 33, 45, 52, and 58 (Chesson, 2016). Together, these
types are responsible for about 90% of cervical cancer cases (ACS, 2018).
The current HPV vaccines guard against viral infections and contain virus-like particles
(VLPs) that are comprised of surface components from the real HPV virus. The VLPs do not
contain the virus’s DNA and therefore do not lead to infection of the real HPV virus upon
vaccination. Since virus-like particles closely resemble the real virus, the body stimulates
production of antibodies and these bind to the protein to prevent it from infecting healthy cells.
Later, if the natural HPV virus enters the body, antibodies will recognize it, bind to the virus at a
much faster response rate, and thus prevent infection (NCI, 2019). The strong immunogenic
properties that the VLPs produce make the vaccines highly effective.
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A highly significant component in determining the effectiveness of a vaccine is the
component’s uptake characteristics. Understanding dosage requirements and following the
appropriate recommendations are critical. For example, according to the most up to date
recommendations provided by the CDCs Advisory Committee on Immunization Practices
(ACIP), 9-14 year old adolescent males and females should receive a 2-dose series before their
15th birthdays with the second dose administered 6-12 months after the first dose. For both
males and females between the ages of 15-26, a 3-dose series is recommended for those who
receive their dose on or after their 15th birthday and for people with immunocompromising
conditions. Following a 3-dose series schedule means that the second dose should be given 1-2
months after the first dose and the final dose should be given 6 months after the first dose.
Effective primary prevention depends upon knowledgeable providers and knowledgeable
patients.
1.9 Secondary Prevention of Cervical Cancer: Medical Screening
The secondary level of cancer prevention includes the regular use of cancer screening
tests. As stated by the National Cancer Institute, cancer screening refers to the detection of precancerous or early cancer signs, when no apparent symptoms are present, with the overall goal of
decreasing cancer related morbidity and mortality. For cervical cancer screening, the most
widely used screening test is the Papanicolaou (Pap) exam and more recently the HPV exam
(CDC,2019). These two screening tools allow for early detection of cervical cancer or early
identification of precancerous lesions. The Pap exam is used to identify changes in cells of the
cervix or abnormal cells. During the test, cells of the cervix are lightly brushed or scraped off
and then sent for laboratory analysis (ACS, 2017). Pap exams are effective in finding
precancerous cells and cancer cells. The HPV exam checks for the human papilloma virus that
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causes the cell changes or abnormal cells; the HPV and Pap tests can be conducted
simultaneously.
Major professional groups such as the American Cancer Society (ACS), the American
College of Obstetricians and Gynecologists and the US Preventive Services Task Force
(USPSTF) have set forth recommendations and guidelines for screening exams in order to detect
and/or reduce cancer-related mortality among individuals who may not be experiencing cancerrelated symptoms (CDC, 2019). While individuals are free to select which recommendations to
follow, the USPSTF recommendations are considered hereon after and are outlined in table 1.

Table 1. US Preventive Services Task Force (USPSTF) Cervical Cancer Recommendation
Summary
Table 1. Recommendation Summary
Population

Recommendation

Grade

Women aged 21
to 65 years

The USPSTF recommends screening for cervical cancer every 3
years with cervical cytology alone in women aged 21 to 29 years.
For women aged 30 to 65 years, the USPSTF recommends
screening every 3 years with cervical cytology alone, every 5 years
with high-risk human papillomavirus (hrHPV) testing alone, or
every 5 years with hrHPV testing in combination with cytology
(cotesting).

A

See the Clinical Considerations section for the relative benefits and
harms of alternative screening strategies for women 21 years or
older.
Women older
than 65 years

The USPSTF recommends against screening for cervical cancer in
women older than 65 years who have had adequate prior screening
and are not otherwise at high risk for cervical cancer.

D

See the Clinical Considerations section for discussion of adequate
prior screening and risk factors that support screening after age 65
years.
Women younger
than 21 years

The USPSTF recommends against screening for cervical cancer in
women younger than 21 years.
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D

Table 1. Recommendation Summary
Population

Recommendation

Grade

Women who
have had a
hysterectomy

The USPSTF recommends against screening for cervical cancer in
women who have had a hysterectomy with removal of the cervix
and do not have a history of a high-grade precancerous lesion
(cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical
cancer.

D

The U.S. Preventive Services Task Force (USPSTF) assigns one of five letter grades (A, B, C, D, or I).
Grade A: The USPSTF recommends the service. There is high certainty that the net benefit is substantial. Grade D:
The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit
or that the harms outweigh the benefits. Source: https://www.cdc.gov/Cancer/cervical/pdf/guidelines.pdf

Sauer et al., reviewed cancer screening use among US adults in 2017. Concerning
cervical cancer screening, for over three decades Pap exams have reduced incidence and
mortality rates by 50%. However, even though Pap test screening prevalence in the US has
exceeded 80% in the overall population of women since 1987, it remained lower in certain
racial/ethnic populations of women. In 2015, Pap test use was similar among black and white
women (84.7%, 83.1% respectively) but was lower among women of the following origins;
77.4% Hispanic, 73.3% Asian, and 70.9% American Indian/Alaskan Native. Further analysis that
evaluated recent Pap test use (within 3 years) revealed it was lowest among specific subgroups of
women which included uninsured and immigrant women (60.8%, 68.2% respectively). This is
consistent with other literature findings that have additionally found the lowest rates of Pap
screening among women with less than high school education, women with the lowest incomes,
and women living in certain regions such as the US-Mexico border (ACS, 2018; Fernandez,
2009).
Of significant concern, are Hispanic women who have lower cervical cancer screening
rates than non-Hispanic white women (Flores, 2013). A cervical cancer screening analysis
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conducted across all Hispanic subgroups revealed that Mexican women had one of the lowest
cervical cancer screening rates, lower than women of Cuban origin (ACS, 2018). However,
findings from another study revealed that Mexican women had the lowest Pap screening rates
when compared to other subgroups of Hispanic women (Cokkinides, Bandi, 2012).
1.10 Tertiary Intervention Approaches: Managing Cancer
Tertiary cancer treatment entails interventions that focus on the management of a cervical
cancer diagnosis and includes treatment and palliative care. This type of intervention is for
individuals who have been diagnosed with cancer with the intent of inducing and maintaining
cancer remission for as long as possible. Due to great strides in research and medical
advancements, treatment of cervical cancer has improved greatly. Included in each of these three
levels of prevention/intervention is increasing disease education for the promotion of behavioral
change, including increased adoption of preventative vaccines and screening (Davis, 2002).
1.11 Barriers to Cervical Cancer Screening
Past literature has identified personal, cultural, socioeconomic and institutional barriers
to cervical cancer screening among US Hispanic women (Watts, 2009). Other very important
barriers that have been less explored include cervical cancer disease health knowledge and health
literacy. However, it is critical to consider these in order to reduce the cervical cancer burden and
improve cervical cancer outcomes among high-risk Hispanic women.
When considering health knowledge, health literacy may also be linked but it is important
to understand that they are two different concepts. For example, one definition provided by Chin
et al., on “health knowledge” refers to facts, information, and skills acquired through experience
or education, and theoretical or practical understanding of a subject related to health and healthcare (Chin et al, 2015).
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Health literacy on the other hand, is ever evolving; it is conceptualized into numerous
theories that may integrate hierarchical levels such as functional, interactive, and critical health
literacy (Nutbeam, 2008) and /or additional components such as attitudes, beliefs, and societal
norms and expectations that can impact how a person makes use of health/disease knowledge
specifically for disease prevention. Adding to the complexity of health literacy is the role “health
knowledge” plays within “health literacy” as it is still largely debated across models and
definitions in the literature. For instance, Gellert & Tille, provide an overview of three separate
health literacy theories that conceptualize the role of heath knowledge as either an antecedent, a
domain of health literacy, or as a consequence of health literacy (Gellert, Tille, 2015).
1.12 Cervical Cancer Knowledge and Health literacy
In addition to primary, secondary and tertiary level interventions, prevention through
health education is key in implementing the comprehensive approach. Past studies have shown
that having cervical cancer knowledge is not a sole predictor for cervical cancer screening
(Watts, 2009); attitudes and beliefs (components of “health literacy”) are other significant
predictors that have been shown to influence behavior for Pap smear uptake (Suarez, 1997;
Chavez, 1995). Despite this, knowledge but not attitudes regarding cervical cancer and
screening, were shown to influence behavior change with regard to increasing cervical cancer
screening and decreasing the burden of cervical cancer (Ramirez, 2000).
In a qualitative study conducted by Torres et al., 45 US Latina women were followed up
after having participated in a community-based educational program to understand influential
factors related to decision-making for breast or cervical cancer screening. After participating in
the cancer education program, they reported increased knowledge about screening guidelines,
HPV, the importance of early screening and information on free and low-cost cancer screening
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resources. More importantly, feelings of “empowerment” were stated which led to an increased
sense of confidence and motivation to take better care of their health (Torres, 2013).
Furthermore, the women mentioned that the tailored educational program along with the
resource- related information that was in a language they could understand was an important
benefit of the program that influenced their overall health-seeking behavior and screening
utilization.
In another recent study, a systematic and meta-analysis review examined evidence on 1)
the effect of cervical cancer education to improve cervical cancer screening rates and 2) the
effectiveness of provider recommendations for cervical cancer screening on screening rates in
diverse high-risk women (Musa, 2017). Pertaining to the first, findings from five studies
examined revealed that the implementation of theory-based educational interventions that were
culturally and linguistically-sensitive and integrated a community-participatory model, had a
positive effect on screening rates. Importantly, these types of interventions increased cervical
cancer awareness, knowledge, emphasized the importance of screening and offered barrier
counseling and guidance with scheduling for cervical cancer screening appointments (CalderonMora et al., 2020; Shokar et al., 2019; Musa, 2017; Nuno, 2011; Hou, 2002; Byrd, 2013; Mishra,
2009; Taylor, 2002).
Other research has shown that timely screening can be associated with both health
literacy and knowledge regarding a target disease (Flores, 2019). A systematic review found a
trend suggesting that limited health literacy and knowledge of a target disease could predict
screening rates (Oldach & Katz, 2014). Determining gaps in knowledge and health literacy
among high-risk women regarding cervical cancer may prove to be critical for improving
screening rates and early detection.
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1.13 Family History of Disease
Other research, though inconsistent, has explored the influence of an individual’s family
history of a particular disease(s) on screening practices and/or knowledge about the disease. In a
study conducted by Williams et al., it was found that among African American women and nonHispanic white women who had a family history of any cancer in an immediate family member,
higher cervical cancer screening rates were completed as compared to women who did not report
a family history of disease for any cancer (Williams et al., 2009). However, Bird et al., who
assessed the level of knowledge, attitudes and screening behaviors among Mexican women
residing along a US-Mexico border city with and without a family history of breast cancer
revealed opposite findings. In that particular study, there were no statistically significant
differences in breast cancer screening practices between women with and without a positive
family history of breast cancer (Bird, 2011). Furthermore, knowledge of breast cancer and
screening did not differ significantly among women with a family history of disease and those
with no family history of disease.
1.14 Gaps in Knowledge
Gaps in cervical cancer knowledge and screening still exist globally, especially in middle
and low-income countries such as Ethiopia, Tanzania, and Cambodia (Chaka, 2018; Mabelele,
2018; Touch, 2018). These gaps also exist in high-income countries such as in the United States
but are more commonly found among underserved populations such as US Hispanic women. In a
study conducted by Document et al., it was revealed that among low-income and minority
populations, those of which included African American, Amish, Appalachian, and Latina
women, awareness of cancer risk and screening was low. Most of the participants had inaccurate
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information about cancer risks, screening guidelines respective to their age, frequency of
screening, and the types of screening needed (Document et al., 2008).
Another study by Byrd et al., conducted among 84 women living along the US-Mexico
border revealed that although most participants had knowledge about cervical cancer and the Pap
exam, they too were unsure about screening guidelines and the recommended frequency of the
exam. Furthermore, women also had misconceptions regarding the causes of cervical cancer and
none mentioned HPV as a cause (Byrd, 2007). However, women identified that better education
on cervical cancer and on the Pap exam would serve as an important facilitator for the uptake of
cervical cancer screening.
1.15 Lack of Standardized Instruments on Cervical Cancer Knowledge and Health
Literacy for US Hispanic Women
As aforementioned, several studies in relation to cervical cancer have been conducted in
different parts of the world on women to assess major theoretical constructs employed in health
behavior research. These studies have included examining barriers, attitudes, beliefs, perceived
vulnerability, self-efficacy and knowledge. Consequently, several varied instruments have been
created to quantitatively measure these constructs. Despite these efforts, there currently exists a
lack of standardized instruments and more specifically knowledge scales that can effectively
measure cervical cancer knowledge among underserved populations. Furthermore, the few that
do exist have been conducted on non-Hispanic women and/or have measured different constructs
that do not necessarily measure specific health disease knowledge.
In a study conducted by Simon et al. in 2012, two instruments were developed and
standardized by a panel of experts to measure ovarian and cervical cancer awareness of
symptoms and risk factors among female postgraduate students (Simon, 2011). These
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instruments were created to assess population levels of awareness, to track changes in awareness
over time, and to evaluate awareness-raising interventions. A separate cross-sectional study
conducted in Ethiopia also developed and validated a questionnaire to describe the knowledge
and attitudes of cervical and breast cancer among women aged 18 and older living in specific
regions of Ethiopia (Chaka, 2018). However, both studies were conducted in different
geographical regions and were made up of different demographic profiles, meaning they were
tailored for non-Hispanic women.
One of a very few cervical cancer standardized instruments created for US Hispanic
women, more specifically for Mexican American women, includes a cervical cancer screening
self-efficacy scale (Fernandez, 2009). However, this scale focuses on one component of health
literacy- self efficacy, and does not explicitly state the role of health knowledge. While the scale
was developed for low-income status women, it was created for women fifty years of age and
older and did not consider younger participants. A separate study that did include young US
Hispanic women (18-25 years) was conducted by Byrd et al. and it evaluated beliefs and
attitudes about cervical cancer screening and prior screening history. However, it did not use a
standardized scale to assess cervical cancer knowledge (Byrd, 2004).
At present, there is one scale, the Cervical Cancer Literacy Assessment Tool (C-CLAT)
that is used for the assessment of functional cervical cancer health literacy (Williams, 2013).
Functional cervical cancer health literacy is defined as “a woman’s functional understanding of
her personal and familial risk of the disease, including how to minimize her risk and the risk to
her family through preventive early detection screenings and life style changes and how to access
the health care system and engage providers to minimize her risk and the risk of to her family”
(Williams 2013; Williams, Mullan & Fletcher, 2007). It focuses on three specific cervical cancer
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content domains- Awareness, Knowledge, and Prevention/Control. Equally important is the fact
that this scale has been validated for use among Black, Arab, and Latina women and can be
administered by a lay person for use in community-based health promotion interventions. For
these reasons, the C-CLAT scale was chosen for the present study.
1.16 Research Aims
While several initiatives have been implemented in an effort to address the cervical
cancer disparity, gaps in knowledge and health literacy still persist and cervical cancer incidence
rates continue to increase among certain US Hispanic women living along the US-Mexico
border. Therefore, it is imperative to effectively assess these gaps so that targeted interventions
can address them while simultaneously promoting cervical cancer health education.
The aims of this study involved two 1) to determine unqueued knowledge of cervical
cancer in high-risk Hispanic women living in the Texas, El Paso border region 2) to determine
functional cervical cancer health literacy in high-risk Hispanic women living in the Texas, El
Paso border region. Data from this study also explored the debate on whether cervical cancer
health knowledge is likely to precede, be a part of, or follow cervical cancer health literacy.
There are specific justifications why this needed to be done. The first is that even though
prior studies conducted over the last two decades have examined attitudes, perceptions, and other
factors such as disease/health knowledge surrounding cervical cancer and its relation to
screening behaviors among US Hispanic women, most have not used standardized scales to
measure such constructs. Moreover, the most common approach for data collection has mostly
been quantitative (i.e. close ended questions) while much less have focused on qualitative data
(i.e. open-ended questions). However, qualitative data can be beneficial in capturing raw and
valuable data that may be able to identify gaps in knowledge that quantitative data may not be
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able to do. Secondly, similar to cervical cancer health knowledge, there are not many studies that
have assessed health literacy specifically for cervical cancer using standardized instruments
among underserved populations. This may be partially explained by the unclear definition of
health literacy and the various theories that measure different constructs. Thirdly, while more
research has been conducted among US Hispanic women, it has not always been inclusive of
underserved high- risk young women that are 18 years of age and older (Byrd, 2004; Kim, 2015).
Examining cervical cancer knowledge among younger women may also have surprising findings
with the relatively recent wide spread availability of the HPV vaccine among younger
demographic groups in the US. Moreover, having a diverse sample in age is important when
implementing a comprehensive multidisciplinary approach that spans across a person’s life span.
Especially because cervical cancer can be prevented if cervical changes are discovered early on
and treated.
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2. METHODS 2
One proposed strategy to reduce the racial/ethnic health disparity surrounding cervical
cancer among US Hispanic women is to assess the current knowledge base of cervical cancer
and other potential factors such as health literacy that may be influencing cervical cancer
screening of the high-risk population. Results from such data can lead to the development or
improvement of interventions that can increase the uptake and timely screening of cervical
cancer among underserved populations. The methods described are approved by the UTEP
Institutional Review Board (Study # 13532261-1, C. Costa, PI).
2.1 Hypotheses
H1: As compared to participants without cervical cancer knowledge (as determined using the
CCQ), participants with cervical cancer knowledge will have higher cervical cancer functional
health literacy (significant higher scores on the C-CLAT).
H2: Participants with a family history of cancer will have higher C-CLAT (cervical cancer
functional health literacy) percentage scores than participants with no family history of cancer.
Other exploratory hypotheses
1) As compared to women who have not received cervical cancer information in the past,
women who have received cervical cancer information from one, or 2 or more sources
will have higher C-CLAT percentage scores.
2) As compared to women who have not received printed cervical cancer information in the
past, women who have received printed cervical cancer information will have higher CCLAT percentage scores.

Study methods were adapted and amended due to the COVID-19 state order restrictions and social distancing
requirements.

2

23

3) As compared to women who did not receive cervical cancer information in the past,
women who have received cervical cancer information from one, or 2 or more sources
will have cervical cancer knowledge.
4) As compared to women who did not receive cervical cancer printed information in the
past, women who did receive cervical cancer printed information will have cervical
cancer knowledge.
5) As compared to women who did not have recent pap exams (within the last 3 years),
women who did have recent pap exams (within the last 3 years) will have higher CCLAT percentage scores.
2.2 Study Participants
Study participants included Hispanic women between the ages of 18-65 years
living in the border region of El Paso, TX. Recruitment of participants took place from May to
June 2020 via health clinic flyers and word of mouth from downtown El Paso neighborhoods.
Women who chose to participate called the PI at the number provided on the flyer. Women were
read a consent form in the language of their choice (English or Spanish) and once the participants
had no more questions, they were asked to provide verbal consent as approval of their voluntary
participation. They were then asked to answer questions from the two questionnaires. The study
sample size included 85 women.
2.3 Study Design
A cross sectional, mixed methods study design was used to assess unqueued cervical
cancer knowledge and functional cervical cancer health literacy. This study design allowed for
the examination of other individual factors (income level, education, family history of disease)
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that may have predicted higher and lower levels of knowledge and health literacy pertaining to
cervical cancer among high-risk Hispanic women living in a US-Mexico border region.
2.4 Measures
For the purpose of this study, the “Cervical Cancer Questionnaire” (CCQ) was developed
to gain a more profound assessment of cervical cancer “perceived self-knowledge” and
“knowledge” among a specific subgroup of US Hispanic women living in a US-Mexico border
region. Questions for the CCQ were adapted from other questionnaires that sought to assess
cervical cancer knowledge, awareness, and knowledge of risk factors and cervical cancer
screening practices.
The CCQ is a questionnaire that captured both quantitative and qualitative/descriptive
data. It provided a total of twenty-five structured questions from determining the following
information: basic demographics (age, marital status, heritage, education level, income level, and
household number); self-reported anthropometric measures (height, weight, and a yes/no/don’t
know question about overweight and obese); three open- and closed-ended questions- perceivedself-knowledge of cancer (whether the woman says she knows what cancer is (yes/no);
knowledge of cancer (whether the woman can correctly state what cancer is); perceived-selfknowledge of cervical cancer (whether the woman says she knows what cervical cancer is
(yes/no); knowledge of cervical cancer (whether the woman can correctly state what cervical
cancer is); perceived self-knowledge of what causes cervical cancer (yes/no); and knowledge of
what causes cervical cancer (whether the woman can correctly state at least one cause of cervical
cancer).
One question had a combination of both a close-ended and open-ended response and
participants were allowed to select more than one option. This question was for the receipt of
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cervical cancer information (type and source). The question queried participants to select an
option(s) of where they had received cervical cancer information and also a brief explanation on
who or where the source may have been obtained from. The next question queried receipt of
cervical cancer printed information (yes/no). If participants responded “yes” to having previously
received cervical cancer printed information, they were then asked an additional four closeended questions (yes/no) that asked about language understanding of the printed information,
questions asked about the printed information, trust of printed information, and whether or not
participants believed the information that was provided to them.
The next questions captured self-reported cervical cancer screening (yes/no and year),
self-reported vaccine history table (influenza, human papillomavirus (HPV), pneumonia,
Hepatitis A, Hepatitis B); and self-reported family history of disease (for first-degree, seconddegree, and third-degree relatives) regarding for health problems related to cancer, metabolism,
heart, respiration, organ function, mental health, and sexually transmitted infections (STIs).
All close-ended items on the CCQ were scored qualitatively (yes/no). With regard to the
open-ended items, responses were carefully peer evaluated and qualitatively rated as “correct” or
“incorrect.” Only two of the open-ended and closed-ended questions were used for analysis in
this paper. These included perceived-self-knowledge of cervical cancer (whether the woman says
she knows what cervical cancer is (yes/no); knowledge of cervical cancer (whether the woman
can correctly state what cervical cancer is); perceived self-knowledge of what causes cervical
cancer (yes/no); and knowledge of what causes cervical cancer (whether the woman can
correctly state at least one cause of cervical cancer). To determine a rating for the open-ended
items, a list of key words/phrases was first devised and compared to the list of the women’s
responses; one list for knowledge of cervical cancer and one for knowledge of what causes
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cervical cancer see appendix page 80. These key words/phrases were established based on the
current literature that provided definitions for cervical cancer and previously identified risk
factors for cervical cancer.
The ratings were then used in different combinations to examine whether women’s
perceptions of knowledge accurately reflected stated knowledge. From this, a final (yes/no)
rating for basic cervical cancer “knowledge” was assigned for each woman, based on the
following criteria: correct/incorrect rated response for question Q10b: Please explain what
cervical cancer is; correct/incorrect rated response for question Q13b: Please explain what
contributes to cervical cancer. If both cervical cancer knowledge (Q10b) and what contributes to
cervical cancer knowledge (Q13b) were rated as “correct” (based on the list of key
words/phrases) women were assigned a rating of “knowledgeable.” If one or both questions were
rated as incorrect, then the woman was assigned a rating of “not knowledgeable.”
To assess health literacy and more specifically functional cervical cancer health literacy, a
standardized instrument known as the Cervical Cancer Literacy Assessment Tool (C-CLAT) was
administered (Williams, 2009). The C-CLAT includes 21 items that measured functional cervical
cancer health literacy through true/false and multiple-choice questions. Three content domains
for cervical cancer were queried- Awareness, Knowledge, and Prevention/Control. All items but
one (Q15) were summed for a final score that determined whether participants had “passing” or
“non-passing” levels of functional cervical cancer health literacy based on the established
passing value of ≥0.75. Question 15 was a “neutral” item that asked about belief of whether
cervical cancer resources were available in the community or not and therefore omitted in the
calculation. Each participant completed both a CCQ and C-CLAT questionnaire.
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2.5 Data Collection Procedures
Women were recruited via health clinic flyers and word-of-mouth from downtown El
Paso neighborhoods and surrounding neighborhoods in the border region. A simple cell phone
was purchased just for the study and contact slips with study eligibility information and phone
number were distributed to the health clinics. Enrollment in the study was sequential, according
to participant phone calls. When participants called they were read the consent form in the
language of their choice (Spanish or English) and once they provide their verbal approval, the
two questionnaires were administered. The PI documented all the response provided by the
partipcants Upon completion, the PI offered an optional review of the C-CLAT assessment and
provided a basic overview of the educational/informational material to the participant and
answered questions. Participants received an incentive card number with a redemption code over
the phone upon completion.
To avoid queueing certain concepts, the CCQ was administered first in an attempt to
capture true cervical cancer perceptions and ultimately knowledge among the participants; total
time was approximately 20-30 minutes. Afterwards, the C-CLAT was administered and lasted
approximately 5 minutes. The PI administered both questionnaires orally. After completion of
both questionnaires, participants received two resources: 1) a printed fact sheet with basic
cervical cancer information and 2) a directory of services for HPV vaccination. Participants had
the option of receiving a 5-10-minute educational briefing of the resource information if they
requested to do so. All materials and vocal interactions were provided in the language preference
of the participant, English or Spanish.
While no personally identifying data was collected from the women, measures were put
in place throughout the study to protect the data collected and to ensure the highest quality
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results. All data was entered as the data was being collected and checked for accuracy using a
triple-check method. As data were being collected, the descriptive characteristics of the data
were checked to ensure that there were no issues with the collection or integrity of the data.
When all data was collected, descriptive analyses were conducted to determine the proportions of
answers obtained, examine trends in the data, and to characterize the sample.
2.6 Statistical Analysis
Data was entered into an Excel database. Data analysis was conducted for a total of 85
participants using SPSS for descriptive and inferential statistics. Descriptive statistics showed the
characteristics of the sample population. Inferential statistics were used to examine the
association for the variables of interest from the CCQ (cervical cancer knowledge, received
cervical cancer information, received cervical cancer printed information, cervical cancer
screening, family history of disease) and from the C-CLAT the C-CLAT percentage score
variable (functional cervical cancer health literacy). Analysis of variance, chi-square models, and
one t-test were used to test the planned hypotheses and exploratory questions.
Inferential analyses were conducted to statistically test the differences observed. The
first analysis examined whether there was an association between “knowledge” as rated by the
CCQ and C-CLAT percentage scores. Whether “knowledge” is required for “literacy” is debated
in the literature, thus the goal of this analysis was to test the relationship between these
constructs. The model compared the C-CLAT percentage scores of participants with and without
“cervical cancer knowledge” and included family history of cancer in self or first-degree
relatives, because it was reasoned that experiencing cancer was likely to yield higher knowledge
(and perhaps literacy). There were certain variables that were not analyzed in this study, however
the they may be analyzed in the near future.
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3. RESULTS
A total of 85 women completed the Cervical Cancer Questionnaire and the Cervical
Cancer Literacy Assessment Tool (C-CLAT). Women were recruited via health clinic flyers and
word-of-mouth from downtown El Paso neighborhoods and surrounding neighborhoods in the
border region. Approximately eight hundred flyers were distributed. Given stay-at-home order
and requirements for social distancing, all women were interviewed by phone (described in detail
in Methods, page xx above).
3.1 Descriptive Statistics
The mean age of the sample was 42.79 (SD 13.23) see table 2. All of the participants selfidentified as Hispanic/Latina and when asked about their heritage, three quarters, 75.3%,
reported being of Mexican ancestry while 18.8% reported being of Mexican-American ancestry
and 5.95% reported being of two or more backgrounds. Nearly half of the participants, 47.1%,
had an annual income of $10,000 to less than $25,000 while 18.8% reported no annual income
and 16.5% reported making less than $10,000 per year. Additionally, nearly half of the
participants, 47.1%, reported being currently married and one quarter, 25.9%, reported never
being married. Pertaining to educational attainment, approximately one quarter (24.7%) reported
being high school graduates; slightly fewer reported having less than a high school education
(21.2%); and (17.6%) had undergraduate degrees. Half of the participants, 50.6%, chose
Spanish as their language of preference when conducting the questionnaires while the other half,
49.4%, chose English as their primary language.
In addition to basic demographic information, the Cervical Cancer Questionnaire (CCQ)
queried cervical cancer knowledge as shown in Table 3.

30

Responses to the Cervical Cancer Questionnaire knowledge questions (“perceived selfknowledge” and “knowledge”) were first examined followed by a final “knowledge” rating.
When first asked (Do you know what cervical cancer is?) a majority of participants (76.3%)
believed they knew what cervical cancer was (yes/no), and all but one participant, (75.3%)
offered a knowledge explanation. However, only about half (56.5%) could in fact accurately
explain cervical cancer. With regard to perceived self-knowledge of what contributes to cervical
cancer, less than half of the participants (43.5%) believed they knew and all but one participant
(42.4%), offered a knowledge explanation. Of those who did, only about one third (31.8%),
could accurately state one or more causes such as persistent HPV infection, multiple sex
partners, and/or smoking. With regard to final “knowledge” ratings, approximately one quarter
of participants (27.1%) were “knowledgeable” (approximately three quarters (72.9%) did not
know what cervical cancer was and/or could not state one or more causes). The CCQ also
queried women about the number of sources of where they had previously received cervical
cancer information and whether or not (yes/no) they had received printed information. Nearly
half (48.2%), reported having previously received cervical cancer information from at least one
source and approximately one third (31.8%) reported having previously received cervical cancer
printed information. The majority of participants (81.2%) reported having recent pap exams
(within the last 3 years).
Among the women participants, family history for any cancer type was reported for self,
first-degree, second-degree, and third-degree relatives. Those who reported a positive family
history of cancer included 69.4%; of those with a positive family history of cancer, 34.1% had a
personal experience of cancer or cancer had occurred in a first-degree relative. In the tested
hypotheses below, family history of cancer (in self or in a first-degree relative, yes/no) was used
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as a control variable because it was reasoned that having a personal experience with cancer
would be likely to increase knowledge.
The Cervical Cancer Literacy Assessment Tool (C-CLAT) was administered to measure
cervical cancer “functional health literacy” (see Methods, page 26 above) and was used as the
outcome variable for the primary hypotheses. Table 4 shows the means (SDs) and percentages
of women meeting criteria for “cervical cancer functional health literacy.” The mean C-CLAT
percentage score was 0.73 (SD 0.12) which was below the established C-CLAT “passing” score
of (0.75). Similarly, there were approximately equal proportions of passing vs non-passing
scores pertaining to cervical cancer functional health literacy; 54.1% and 45.9% respectively.
Table 2: Demographics and Characteristics of Study Population Results N=85
Variable
Age (mean, SD)
42.79
N
Language
Spanish
43/85
English
42/85
Ethnicity
Mexican
64/85
Mexican American
16/85
2 or more ethnicities
5/85
Annual Income
No income
16/85
Less than $10,000 per year
14/85
$10,000 to less than $25,000
40/85
$25,000 to less than $50,000
12/85
$50,000 or more
3/85
Family Composition
Married
40/85
Divorced/Separated
12/85
Widowed
3/85
Never Married
22/85
Unmarried Couple/Living
8/85
with a partner
Education
Less than High School
18/85
GED
9/85
High School Graduate
21/85
32

13.23
%
50.6
49.4
75.3
18.8
5.9
18.8
16.5
47.1
14.1
3.5
47.1
14.1
3.5
25.9
9.4
21.2
10.6
24.7

Technical School Graduate
Associates Degree
Undergraduate Degree
Graduate Degree

5/85
7/85
15/85
10/85

5.9
8.2
17.6
11.8

Table 3: Knowledge-Base of Cervical Cancer Results from Cervical Cancer Questionnaire
(CCQ)
Variable
N
%
Perceived self-knowledge of cervical cancer (Q10a: Do
you know what cervical cancer is?)
Yes
No
65/85
76.5
20/85
23.5
Knowledge of cervical cancer (Q10b: Please explain
what cervical cancer is.)
Yes (offered an explanation on what it is)
64/85
75.3
No (Did not offer an explanation on what it is)
21/85
24.7
Rating for knowledge
Correct
48/85
56.5
Incorrect
37/85
43.5
Perceived self-knowledge of what contributes to cervical
cancer (Q13a: Do you believe you understand what
contributes to a person getting cervical cancer?)
Yes
37/85
43.5
No
48/85
56.5
Knowledge of what contributes to cervical cancer (Q13b:
Please explain what contributes…)
Yes (offered an explanation on what it is)
No (Did not offer an explanation on what it is)
36/85
42.4
49/85
57.6
Rating for Knowledge of what contributes to cervical
cancer
Correct
27/85
31.8
Incorrect
58/85
68.2
Overall cervical cancer basic knowledge rating
(Knowledge of cervical cancer + Knowledge of what
contributes to cervical cancer )
Knowledgeable (both answers correct)
23/85
27.1
Not Knowledgeable (one or both answers
62/85
72.9
incorrect)
Sources of Cervical Cancer Information
No information received
13/85
15.3
1 source
41/85
48.2
2 or more sources
31/85
36.5
Cervical Cancer Printed Information
Yes
27/85
31.8
33

No
Recent pap exam (within last 3 years)
Yes
No
Family hx of any cancer (self, 1st, 2nd and/or 3rd degree
relatives)
Yes
No
Missing
Family hx of any cancer (self & first-degree relatives)
Yes
No
Missing

58/85

68.2

69/85
16/85

81.2
18.8

59/85
25/85
1/85

69.4
29.4
1.2

29/85
55/85
1/85

34.1
64.7
1.2

Table 4: Cervical Cancer Literacy Assessment Tool (C-CLAT) Results N=85
Variable
C-CLAT % score (mean, SD)
.7318
Functional Health Literacy
Yes
No

.1236

N

%

46/85
39/85

54.1
45.9

3.2 Inferential Statistics
Prior to conducting the planned analyses, the distribution of the main outcome variable,
the C-CLAT score distribution was tested for normality. The histogram of values is shown in
Figure 1. A Shapiro-Wilk’s test was performed and the results are presented in Table 5. Based on
both test results, C-CLAT percentage score was treated as normally distributed.
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Figure 1

Table 5: Test of Normality for C-CLAT %
Tests of Normality
Shapiro-Wilk
Statistic

CLAT%

.966

df

Sig.
85

.024

a. Lilliefors Significance Correction

35

Analysis of variance and chi-square models were used to test the planned hypotheses and
exploratory questions. For the primary hypotheses, one ANOVA model was used to test both
hypotheses. The model tested whether two predictive factors, “cervical cancer knowledge” (main
effect, CCQ) and “family history of cancer” (main effect, CCQ) predicted C-CLAT percentage
scores. The interaction of knowledge and family history of cancer was also tested. Table 6
shows the results. The model was significant (F = 2.87, df = 3, p = 0.42). There was a main
effect for “cervical cancer knowledge.” “Family history of cancer” was not associated with CCLAT percentage score. Thus, women with basic knowledge of cervical cancer (could state
what cervical cancer was, and at least one cause) scored higher on the measure of cervical cancer
literacy.
Table 6: ANOVA, Tests of Between-Subject Effects for Variables “Cervical Cancer Knowledge”
and “Family History of Cancer”
Dependent Variable: CLAT%
Source

Type III

df

Mean

Sum of

F

Sig.

Square

Squares
Corrected Model

.120a

3

.040

2.868

.042

32.533

1

32.533

2332.065

.000

CQccknow

.076

1

.076

5.440

.022

CQfamhx

.048

1

.048

3.467

.066

CQccknow

.004

1

.004

.298

.587

Error

1.116

80

.014

Total

45.898

84

1.236

83

Intercept

* CQfamhx

Corrected Total

a. R Squared = .097 (Adjusted R Squared = .063)

Two additional hypotheses were tested to explore the possible sources of the effect
observed in the first model. Two additional models were calculated to determine whether having
received prior information on cervical cancer would predict C-CLAT percentage scores. In both
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ANOVA models, two predictive factors were used including “cervical cancer information
received” (yes/no), and “family history of cancer” (yes/no). The main effects and interaction
were tested. The results are shown in Table 7. Receiving any type of prior information on
cervical cancer did not predict C-CLAT scores, and family history of cancer did not influence CCLAT scores.
Table 7: ANOVA, Test of Between-Subjects Effects for Variables “Cervical Cancer Information
Received” and “Family History of Cancer”
Dependent Variable: CLAT%
Source

Type III

df

Mean

Sum of

F

Sig.

Square

Squares
Corrected Model

.121a

5

.024

1.696

.145

31.365

1

31.365

2194.514

.000

CQfamhx

.051

1

.051

3.598

.062

CQinfo

.017

2

.009

.606

.548

CQfamhx

.044

2

.022

1.546

.220

Error

1.115

78

.014

Total

45.898

84

1.236

83

Intercept

*CQinfo

Corrected Total

a. R Squared = .098 (Adjusted R Squared = .040)

The second exploratory analysis tested whether having received prior printed information
might influence C-CLAT scores. The ANOVA model again included family history of cervical
cancer as a control factor and two main effects and the interaction were tested. As shown in
Table 8, neither prior receipt of “printed information on cervical cancer”, nor “family history,”
were significantly associated with C-CLAT scores.
Table 8: ANOVA, Test of Between-Subjects Effects for Variables “Cervical Cancer Printed
Information Received” and “Family History of Cancer”
Dependent Variable: CLAT%
Source

Type III

Df

Mean

Sum of

Square

Squares

37

F

Sig.

Corrected Model

.085a

3

.028

1.973

.125

36.470

1

36.470

2535.057

.000

CQfamhx

.039

1

.039

2.723

.103

CQprint

.038

1

.038

2.661

.107

2.166E-5

1

2.166E-5

.002

.969

Error

1.151

80

.014

Total

45.898

84

1.236

83

Intercept

CQfamhx
* CQprint

Corrected Total

a. R Squared = .069 (Adjusted R Squared = .034)

In a further attempt to understand what past experiences regarding cervical cancer might
predict cervical cancer knowledge (as determined by the CCQ), two chi-square analyses were
also planned to determine whether “cervical cancer knowledge” (yes/no) was associated with
having received prior cervical cancer information, or with having received (specifically) printed
cervical cancer information. Given that family history of cancer was not a significant predictor
in prior models, this variable was not included in these tests.
The variables in the first chi-square test did not allow for further analysis due to low cell
count (one cell size was < 5); data criteria was also not met for a Fischer’s exact analysis.
However, the second Chi-square test was conducted and it showed that having received prior
“cervical cancer printed information” was not associated with “cervical cancer knowledge.” (X2
(df=1, N=85) =3.753, p =.053) (table 9).
Table 9: Chi-Square Test for Variables “Cervical Cancer Printed Information Received” and
“Cervical Cancer Knowledge”
Chi-Square Tests
Value

df

Asymptotic

Exact Sig.

Exact Sig.

Significance

(2-sided)

(1-sided)

(2-sided)
a

Pearson Chi-Square

3.753

1

.053

Continuity Correction

2.806

1

.094

Likelihood Ratio

3.616

1

.057

b
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Fisher's Exact Test

.068

Linear-by-Linear

3.709

1

.049

.054

Association
N of Valid Cases

85

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 7.31.
b. Computed only for a 2x2 table

The final test examined whether women who had recent pap exams (within the last 3
years) would have higher C-CLAT percentage scores as compared to women with no recent pap
exams (within the last 3 years). The analysis showed that among 85 participants, there was no
significant difference in the average C-CLAT percentage scores for women who did have recent
pap exams (within the last 3 years) (M= .7370; SD= .11871) compared to those who did not have
a recent pap exam (within the last 3 years) (M=.7094; SD= .14517) (p0.001) (table 10).

Table 10: T-Test for Variables “recent pap exam” and “C-CLAT percentage scores”
Independent Samples Test
Levene's Test for

t-test for Equality of Means

Equality of Variances
F

Sig.

t

df

Sig. (2-tailed)

Mean

Std. Error

95% Confidence

Differe

Difference

Interval of the

nce

CLAT%

Equal

.913

.342

Difference
Lower

Upper

.802

83

.425

.02758

.03438

-.04080

.09597

.707

19.907

.488

.02758

.03900

-.05380

.10897

variances
assumed
Equal
variances
not
assumed
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4. DISCUSSION
In order to alleviate the marked racial/ethnic health disparity surrounding the high rates
of cervical cancer in Hispanic/Latina women, comprehensive multidisciplinary approaches that
also integrate health education, are needed to improve cervical cancer knowledge and health
literacy and perhaps in turn, increase screening uptake, early detection and ultimately, cervical
cancer fatalities. However, before more appropriate/effective interventions that encompass
health education can be established for such groups, finding gaps in cervical cancer knowledge
and health literacy is essential.
Though research on cervical cancer among US Hispanic women has increased over the
last several years, relatively few studies have examined cervical cancer knowledge in
Hispanic/Latina women, and even fewer have examined cervical cancer health literacy using
standardized instruments.
The goal of this study was to assess uncued cervical cancer knowledge and functional
health literacy among Hispanic women between the ages of 18-65 living in one US-Mexico
border region in El Paso, TX. Upon completion of the questionnaire and C-CLAT assessment,
women were provided with the correct responses for the assessment and had a cervical cancer
educational briefing that included education on what cervical cancer is, who is at risk, risk
factors for cervical cancer, screening guideline recommendations by the CDC, preventive
measures, and information on where to get screened for cervical cancer and HPV immunization
venues.
4.1 Summary of Findings
Descriptive and inferential analyses were conducted. Descriptive analyses revealed that
while a majority of women (75.3%) expressed the belief that they knew what cervical cancer
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was, only about half of those women (56.5%) could actually provide accurate information
regarding the disease. With regard to knowledge of cervical cancer risk factors, fewer than half
(42.4%) expressed the belief that they knew possible risk factors, and only one third of those
women (31.8%) could accurately state one or more risk factors. The number of women rated by
study-specific criteria for “cervical cancer knowledge” yes/no (see Methods page 33 above) was
surprisingly low. Only about one quarter of women queried (27.1%) had basic cervical cancer
“knowledge.”
The descriptive analyses also revealed that only about one half of the women (48.2%)
had previously received cervical cancer information from at least one source; and only about one
third (31.8%) recalled previously receiving cervical cancer information in printed form. Over
three quarters of the participants (81.2%) were current with cervical cancer screening (reported
having had a pap exam with the last 3 years).
With regard to family history of cancer, over half of the women (69.4%) reported a
positive history of cancer among themselves, first-degree, second-degree, and/or third-degree
relative(s). Of those, about half (34.1%) reported having had cancer themselves, or knew of a
cancer occurrence in one or more first-degree relatives.
All participants completed the Cervical Cancer Assessment Tool (C-CLAT), a previously
standardized measure of functional cervical cancer literacy. The mean percentage score was
0.73 (SD 0.12) and fell slightly below the established C-CLAT “passing score” of (0.75). In this
population, 45.9% of women did not achieve a “passing” C-CLAT percentage score.
The analysis revealed that participants with cervical cancer knowledge (CCQ) had
significantly higher C-CLAT percentage scores (higher cervical cancer functional health literacy)
as compared to participants without cervical cancer knowledge. Contrary to expectations, this
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analysis also revealed that having a “family history of cancer” was unrelated to C-CLAT
percentage score.
Given the descriptive findings suggesting the relatively low rates of knowledge and
literacy among participants, the next analyses attempted to understand reasons for the lack of
knowledge and literacy, and to understand whether cervical cancer information remembered by
Hispanic/Latinx women in this sample made any difference, that is, resulted in higher literacy
scores. First, analyses tested whether having previously “received cervical cancer information”
(yes/no) would predict C-CLAT percentage scores (higher cervical cancer functional health
literacy). The analysis revealed that there was no effect of having previously “received cervical
cancer printed information.” The C-CLAT percentage scores of women who had and had not
received prior cervical cancer information did not differ.
Presuming that printed information might have more impact, another model was
calculated to determine whether perhaps having received specifically printed information on
cervical cancer might predict higher C-CLAT scores. Similar to the previous analysis, the CCLAT scores of women who had and had not received prior printed information did not differ.
In other words, having received prior printed information on cervical cancer seemed to have no
relationship to C-CLAT scores. Finally, a chi-square analysis examined whether knowledge
(yes/no) and having received printed information (yes/no) were associated. There was no
association. (The model testing the association between knowledge and “any information” could
not be interpreted due to one or more low count (< 5) cell size which invalidated the model; the
Fischer’s exact model could not be done either due to data not meeting minimum criteria for that
specific model).
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4.2 Cervical Cancer “Knowledge”
Few studies have explored cervical cancer knowledge among US Hispanic women.
Assessing “knowledge” poses many challenges (Watts, 2009; Ramirez, 2000). It is a complex
construct that cannot always be easily measured, and if so, it is not always done using
standardized instruments. In fact, there are few studies that have explored the concept of
knowledge pertaining to cervical cancer among US Hispanic women. One such study conducted
by Byrd et al. did so, and participants were from the same US-Mexico border region as
participants in the study here described. The Byrd et al. study also explored attitudes and
perceptions about cervical cancer and cervical cancer risk. In that study, participants were
interviewed in focus groups, and it was reported that there was a mix of accurate and inaccurate
knowledge, as well as misconceptions of cervical cancer (though specific results were not
stated). This is consistent with findings from this study. Moreover, findings from the Byrd et al.
study revealed that none of the participants in the focus groups were able to identify HPV, or
even a virus, as a cause of cervical cancer. Participants did however mention multiple sexual
partners as a risk factor.
Interestingly, in contrast to the Byrd et al. study, conducted in 2007, participants in the
present study were able to accurately cite one or both of the aforementioned causes in their
responses, in addition to other risk factors. This may suggest some small progress in this region
over the intervening 13 years. This could also be due however to the demographic profile of the
sample in this study, as there were more participants with higher educational attainment in the
present study, as compared to the participants in the Byrd et al. study.
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4.3 Cervical Cancer Health Information
Findings revealed that nearly half (48.2%) of the participants had previously received
cervical cancer information from at least one source. The most commonly remembered sources
of cervical cancer information included verbal information provided by an OBGYN and the
media (ex. tv, internet, radio). The least commonly reported sources of information were from a
family member/relative and or friends/peers. The women were clearly receptive to receiving
cervical cancer information from their physicians in healthcare settings. However, in order for
that to happen, it means that women must first have access to physicians and screening services.
Ensuring this access is foundational for achieving disease reduction.
The findings also suggested that media were another valuable means for communicating
important health education information pertaining to cervical cancer. Further exploration on how
to best incorporate cervical cancer health messages into various media platforms (ex: t v,
internet, radio) may also prove to be effective for cervical cancer knowledge and health literacy
learning. Moreover, it was notable to find that over half of the women participants stated they
had never received printed information regarding cervical cancer. This was surprising given the
vast amount of educational printed material widely available (although not always in the Spanish
language).
4.4. Cervical Cancer Screening
The American Cancer Society reported in 2015, lower up-to-date cervical cancer
screening rates among US Hispanic women as compared to non-Hispanic white women (79% vs
89% respectively). In comparison to the US general population of Hispanic women with up-todate screening (79%), the rate was similar in the present study; over three quarters (81.2%) of the
study participants were current with cervical cancer screening. This finding suggests that the

44

women in the present study had some type of access for screening services for cervical cancer.
Given the high rate of cervical cancer screening, this may also suggest that the women who
participated in the current study may have already had a heightened awareness of cervical cancer
and therefore were more adept to cervical cancer screening.
4.5 Family History of Cancer
Women were very willing to share their family history of cancer. There were a few
instances where women knew that a relative in the family had been diagnosed with cancer but
they either could not recall which type of cancer it was or they simply were unsure because it had
happened a long time ago, or it had occurred in a relative with whom they did not have close
family ties. It was also observed that for some women, having to recall family history disease
made them realize that they could be more susceptible to certain diseases. Reviewing family
history could perhaps be developed as a valuable tool for better sensitizing women to risk of
disease.
4.6 Cervical Cancer Literacy Assessment Tool (C-CLAT)
With regard to the Cervical Cancer Assessment Tool (C-CLAT), the sample mean
percentage score fell below the established C-CLAT “passing score.” Moreover, among those
women who had a passing C-CLAT score, several of the women during the assessment admitted
to not knowing the answers to one or more of the question items and therefore made educated
guesses that turned out to be correct. Thus, the average passing score may be an over-estimate of
what women actually knew.
4.7 Qualitative Observations of Participant’s Responses to C-CLAT Items
The C-CLAT is one of very few cervical cancer literacy rating tools standardized
specifically for Arab, Black, and Latina women. While the tool is a valuable addition to the
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literature, it is important to consider feedback from respondents about the items. For example,
some of the women simply did not understand specific question items even though they were
completing the questionnaire in the language of their choice (either Spanish or English). This in
turn could have led to participants’ inability to know how to answer certain items. These
observations raised important questions about the extent to which the initial standardization
study needs to be replicated with different subpopulations of Hispanic women.
It is also important to highlight that this specific sample of women included residents
living along the US-Mexico border region and therefore, some of the participants answered
questions regarding optimal screening frequency according to screening guidelines established in
Mexico, and not in the U.S. For future studies conducted on the border, it will be important to
capture this variability quantitatively. In other words, one or more additional questions should
be added to indicate on which guidelines the participant is basing their answer.
Upon completing the assessment, women were given the option to review items they did
not answer correctly, and 100% of the participants chose to go over the responses they had
missed with the PI. This was another opportunity to obtain rich qualitative information about
women’s knowledge and C-CLAT scores. For example, several of the participants did not agree
that the correct response for “Getting a Pap test is very painful” should be “false.” When queried
further about their views, participants explained that “women have different pain thresholds;”
“doctors may not always be gentle;” and “women can be different down there” (referring to
depth and size of cervix). During the educational briefing, some women also expressed
concern/disagreement over the screening guidelines established by the CDC, and stated that
screening every three years was too long of a time period, and that annual checkups would be
“safer” in order to prevent and/or detect cervical cancer earlier. In fact, guidelines for Pap
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screenings have shifted around over the past 10 years leaving women confused. They were all
very good points, again raising important questions regarding whether the current C-CLAT
standardization scale is adequate to use in any subpopulation of Latina women.
4.8 Association of Cervical Cancer Knowledge and Higher Health Literacy
Findings from this study revealed that participants that demonstrated “knowledge” had
higher cervical cancer functional health literacy scores. Importantly, this was a simple validation
of the CCQ “knowledge” ratings (yes/no). This finding was also very interesting because prior
research on health literacy has debated the role of health knowledge within health literacy
theories. Research is still exploring whether health knowledge functions as an antecedent of
health literacy, is part of health literacy itself, or is a consequence of health literacy (Gellert &
Tille, 2015). While the primacy of cervical cancer knowledge in health literacy could not be fully
tested in this study, the fact that women with “knowledge” had significantly higher C-CLAT
scores logically suggested that knowledge could be either antecedent or concomitant with
literacy, and, indirectly, did not support the view that knowledge followed literacy. In other
words, this finding was not consistent with the existing literature that suggests health knowledge
happens as a consequence of functional health literacy theories (Berman et al., 2011). More
research is needed to explore this.
4.9 Association of Family History of Cancer and Higher Health Literacy Scores
It was interesting to find that there was no meaningful difference in C-CLAT percentage
scores between women with and without a family history of cancer. It was presumed that women
who reported a positive family history of cancer (for any cancer type) among themselves or a
among a first-degree relative(s), higher cervical cancer functional health literacy scores would be
observed. The analysis showed in fact that experiencing cancer did not confirm any additional
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health literacy among this sample of women. This may suggest that even while women are
undergoing cancer treatment themselves or among a first degree relative, cancer education may
not be happening. If education is happening, it may also suggest that the individuals may not be
processing it at the time or were not seeking it. Other possibilities may include individuals
actively avoiding the education as a coping strategy. Future studies are needed to explore this
phenomenon.
4.10 Association of Cervical Cancer Screening and Higher Health Literacy
One of the major goals of the present study was to access cervical cancer health literacy
because it was assumed that this would be associated with cervical cancer screening.
Surprisingly, there was no association between cervical cancer health literacy and screening
behavior. This means that health literacy scores (as determined by C-CLAT) were not higher
among women who did have recent pap exams (within the last 3 years) as compared to women
who did not have recent pap exams (within the last 3 years). This suggests that despite being
screened, cervical cancer health literacy is not being enhanced.
4.11 Understanding the Sources of Acquired Health Literacy
Another key goal of this study was to examine knowledge and literacy in this sample and
to explore possible factors that might or might not contribute to literacy. Once it was determined
that the mean literacy score for women in this sample was below the C-CLAT “passing” criteria,
it became important to understand how having received prior information might or might not
have influenced literacy. These analyses helped to understand the possible impact of receiving
information on literacy. The analyses showed that cervical cancer functional health literacy
score was not predicted by whether women had previously received any health information
regarding the disease (from one or various sources reported), or whether women had received
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specifically printed information on cervical cancer. Further, analyses showed that knowledge
was not impacted by having received printed information.
These findings supported the notion that health literacy is multidimensional and highly
complex. Consistent with broader health literacy theories, the findings suggested that much more
may be required to build health literacy and knowledge than simply providing someone with
health information, from one or more sources, and printed or not. Most importantly, taken
together, these findings suggested that the current cervical cancer health information is wholly
inadequate when provided to Hispanic women residing in the El Paso border region and
ineffective in building knowledge or literacy.
4.12 Implications of Study Findings for Public Health Practice
This study offered valuable insight on the importance of examining “knowledge” and
functional health literacy pertaining to cervical cancer among US Hispanic women living in the
US-Mexico border region. The finding that only about one quarter of the women were
“knowledgeable” about cervical cancer (that is, could describe what it was and could mention at
least one risk factor) revealed that there is a huge gap in cervical cancer knowledge among highrisk women. This is very concerning. A lack of cervical cancer knowledge has been cited in the
literature as a barrier for cervical cancer screening (Flores, 2013). If cervical cancer screening
rates are to improve and continue, it is imperative to increase cervical cancer knowledge.
Additionally, the finding that only approximately half of the women had “passing”
scores for cervical cancer functional health literacy is also very concerning. Though perhaps
more challenging, increasing cervical cancer health literacy is equally, if not, more important to
increase preventive screening. The literature continues to accumulate evidence for the negative
impact of limited health literacy and health outcomes. Among adults with poor health literacy, it
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has been shown that they have less knowledge of disease management, less knowledge of health
promoting behaviors, report poorer health status, and are less likely to use preventive services
(Wang, 2010).
Approaches for increasing both knowledge and health literacy pertaining to cervical
cancer should be comprehensive and multidisciplinary. According to findings from this study,
receiving health information on cervical cancer did not have an impact on women’s knowledge
or health literacy. However, that does not mean that health information should not be provided.
Rather, it means that the practice of educating women about cervical cancer in medical and
public health communities needs to improve. New models for educating women are needed that
go well beyond the current health information provided. For example, women may need to be
engaged in discussion groups that include role-playing exercises on how to ask questions in
medical settings; they may need video content provided by cancer survivors, and they may need
basic skills training to learn how to find credible health information. Research studies are
needed to pilot and test the efficacy of these and other approaches for changing women’s’
preventive health behaviors.
Women in this study reported receiving cervical cancer information most commonly
from their obstetricians/gynecologists, and through media (ex. tv, internet, radio), two valuable
sources that with some modification can facilitate cervical cancer knowledge and build on health
literacy. Perhaps obstetricians/gynecologists could be taught how to use simpler language when
they provide information about cervical cancer to their patients. More importantly, instead of
solely providing information, they need to engage their patient’s during basic educational
briefings about cervical cancer by asking questions, and “testing” their patients in a collaborative
and engaging way. Through this type of activity, patients have more opportunities to
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communicate and ask open-ended questions. If the obstetricians/gynecologists cannot do this
themselves, perhaps assistants can be trained to do it, and do so in the language of choice of the
patient. Cervical cancer health information shared through media should also be available in both
the Spanish and English languages, include simple and relatable language, and should be
culturally sensitive to the target population. The focus of both health messages should include
minimum prevention behaviors to ensure early disease detection.
To build cervical cancer health literacy, approaches need to go beyond individual’s
knowledge about the disease. This means that cervical cancer health education should also be
reinforced by various materials and not just by handing out pamphlets or other written materials
and assuming it will be read and easily understood. A comprehensive approach needs to happen
over the course of time and not only as a one-time intervention. Integrating health education
interventions across a woman’s life span is essential to build not only knowledge but also health
literacy for improved cervical cancer outcomes.
4.13 Limitations
This study had limitations that are worthy to note. First, the original goal to recruit 150
participants could not be achieved because of stay-at-home orders and requirements for social
distancing. Therefore, a convenience sample was drawn upon which could have led to a biased
sample. This means that the study could have attracted women with an already heightened
awareness of cervical cancer. Additionally, if the sample size had been larger, it may have been
more representative of the population and more analyses could have been conducted to explore
other questions.
The CCQ is not a standardized instrument. Data collected through the questionnaire
queried self-reported data for anthropometric measures, cervical cancer screening, vaccine
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history, and family history of disease. While the questions were carefully designed to be easily
answerable, self-reported data may not have been completely accurate and could not be
validated. Furthermore, self-reported data could have led to recall bias and social desirability
bias. Another limitation may have been introduced by the approach to assigning “knowledge”
ratings. Measuring a construct like knowledge based on information from open-ended questions
is challenging and ultimately subjective. The open-ended items on the CCQ could be improved
to prompt for more structured responses that perhaps would be easier to rate. For example, when
asked “do you know what contributes to cervical cancer?” some participants mentioned barriers
to detecting cervical cancer, instead of cervical cancer risk factors. Additionally, the phrase
“cervical cancer screening” in the English version of the questionnaire was not always clearly
understood to mean utilization of a pap/hpv exam. Adding a question on insurance coverage
would also be helpful for better examination of cervical cancer screening barriers and facilitators.
In reference to the C-CLAT assessment, the Spanish version had some challenges. There
were specific question items that were not easily understood by the participants because certain
words were not common to the vocabulary used by the women participants residing in the USMexico border area. Therefore, modification of certain terms would be beneficial for clearer
understanding and replication of the standardization study in the Spanish language version of the
instrument is needed.
4.14 Conclusions
Despite major decreases in cervical cancer incidence rates in the U.S. over the past
several decades, certain subpopulations of women continue to be disproportionately affected by
it. One of these groups includes US Latina/Hispanic women who have the highest cervical
cancer incidence rates as compared to women from other racial/ethnic minorities. To improve
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detection and prevention in US Latina/Hispanic women, it is critical to understand their current
knowledge and health literacy with regard to cervical cancer. This study was among the first to
explore the association of cervical cancer functional health literacy (using a standardized
instrument [C-CLAT] ) and basic cervical cancer knowledge (as determined by the CCQ) among
both Spanish-speaking and English-speaking participants of mostly Mexican origin. In doing so,
it revealed that only about one quarter of participants were able to demonstrate basic knowledge
of cervical cancer, and approximately half had “passing” scores for cervical cancer functional
health literacy. Furthermore, it revealed that current education regarding cervical cancer among
Latina/Hispanic women in the El Paso border region is may be both seriously lacking and
inadequate when provided. The practice of educating women about cervical cancer must be
greatly enhanced in order to improve cervical cancer outcomes for high-risk Hispanic women
living in the US-Mexico border region. Standardization of the C-CLAT instrument should also
be re-evaluated for use among subgroups of Latina women living in the US.
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5. MPH PROGRAM FOUNDATIONAL COMPETENCIES
There were five MPH program foundational competencies that applied to my thesis. The
first one included: Evidence-based Approaches to Public Health. Under this area I was able to
apply the following components; 1) Select quantitative and qualitative data collection methods
appropriate for a given public health context, 2) Analyze quantitative and qualitative data using
biostatistics, informatics, computer-based programming and software, as appropriate and 3)
Interpret results of data analysis for public health research, policy or practice. The second
foundational competency included Public Health & Health Care Systems. Under this area I was
able to discuss the means by which structural bias, social inequities and racism undermine health
and create challenges to achieving health equity at organizational, community and societal levels.
The third foundational competency included Planning & Management to Promote Health. Under
this area I was able to assess population needs, assets and capacities that affect communities’
health. The fourth foundational competency I applied was Leadership which allowed me to apply
principles of leadership, governance and management, which include creating a vision,
empowering others, fostering collaboration and guiding decision making. The last foundational
competency, included communication. Under this area I was able to communicate audienceappropriate public health content, both in writing and through oral presentation. Furthermore, I
was able to apply one of the MPH program Hispanic and Border Health Concentration
competencies which included stating the principles of prevention and control of disease, and
discuss how these can be modified to accommodate cultural values and practices in Hispanic
border communities.
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7. APPENDIX
Cervical Cancer Questionnaire (CCQ)

Date:___________

Date of Birth:
____________

Subject ID:
__________

Zip Code:
___________

Verbal Consent:
__________

Start Time:__________

End Time:__________

66

This is an anonymous survey; all information collected is for research purposes only.
Section 1: Demographics and Anthropometric
1. What is your marital status?
Divorced/Separated
Married
Widowed
Living with a Partner
Never Married
2. What is your heritage?
Alaska Native
African American
American Indian
Asian
Black
White

Mexican
Mexican
American
Central American
Cuban
Dominican
Puerto Rican

3. What is your highest level of education?
Less than high school
GED
High School Graduate
Technical School Graduate

South American
Spaniard
Native Hawaiian
Pacific Islander
Other:________________

Associates Degree
Undergraduate Degree
Graduate Degree
o Masters
o PhD

4. What is your estimated weekly income?______ monthly?______ No. household family
members:_______
5. What is your height? ______
6. What is your weight? ______
7. Do you consider yourself overweight? Circle one.

Yes

No

Don’t Know

8. Do you consider yourself obese? Circle one.

Yes

No

Don’t Know

Section 2: Knowledge-base
9. Do you know what cancer is? Please explain.
10. Do you know what cervical cancer is? Please explain.

11. How did you learn about cervical cancer? Were you provided any of the following:
Printed information, where:___________
Verbal explanation,
who:______________
Media, please specify:_______________
College Course:______________
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Family member/relative
Friends/peers
Other: ______________
No information

12. When you learned about cervical cancer, were you given printed information?
Yes
No
Not applicable
a. When you learned about cervical cancer, was it in a language you could understand?
Yes
No
Not applicable
b. Did you ask any questions about the information that was given to you?
Yes
No
Not applicable
c. Did you trust the person/organization that gave you the information?
Yes
No
Not applicable
d. Did you believe the information that was given to you?
Yes
No
Not applicable
13. Do you believe you understand what contributes to a person getting cervical cancer?
Yes
No
a. If yes, what do you think contributes to a person getting cervical cancer?

14. Have you ever been screened for cervical cancer?
Yes
No
Why
not?_________________________________________________________________
______
a. When was the last year you got screened for cervical cancer? ________________
Section 3: Vaccine History
Please mark all the vaccines you have received and provide dates when applicable.
Vaccine Type:
Yes No Don’t Last
know Year
Given:
Influenza (Flu)
Human papillomavirus (HPV)
Pneumonia
Hepatitis A
Hepatitis B
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Section 4: Family History of Disease- Please indicate which medical conditions have been
medically diagnosed.
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Cuestionario de Cáncer Cervical

Fecha: ___________

Fecha de
Nacimiento:_____
Codigo Postal:______

ID del Sujeto:______

Consentimiento verbal:
__________________

Hora de Inicio: __________

Hora de Finalización: __________

Lo siguiente es una encuesta anónima; toda información obtenida será solo para uso de estudio.
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Sección 1: Demografía y Antropométrico
15. ¿Cuál es su estado civil?
Divorciado/Separado
Casado
Viudo
Viviendo con un
Nunca Casado
Compañero
16. ¿Cuál es su patrimonio?
Nativo de Alaska
Mejicano
Sudamericano
Afroamericano
Mejicano
Español
Americano
Indio Americano
Americano
Nativo Hawaiano
Central
Asiático
Cubano
Isleño del Pacifico
Etnicidad Negra
Dominicano
Otro:________________
Etnicidad Blanca
Puertorriqueño
17. ¿Cuál es su nivel más alto de educación?
Menos que la preparatoria
Licenciatura en un Asociado
Diploma de educación
Licenciatura
general
Graduado de Preparatoria
Diploma de Posgrado
o Maestría
Graduado de escuela
o Doctorado
técnica
18. ¿Cuál es su ingreso semanal? ______ mensual? ______ Número de miembros en el hogar:
_______
19. ¿Cuál es su estatura? ______
20. ¿Cuál es su peso? ______
21. ¿Se considera ser una persona de sobrepeso? Circule Uno.

Sí

No

No Se

22. ¿Se considera ser una persona obesa? Circule uno.

Sí

No

No Se

Sección 2: Base de Conocimiento
23. ¿Sabe que es el cáncer? Explique en detalle.

24. ¿Sabe que es el cáncer cervical? Explique en detalle.

25. ¿Cómo llego a saber del cáncer cervical? Le proporcionaron uno de los siguientes:
Información impresa,
donde:____________
Explicación Verbal,
quien:______________

Familiar/Pariente
Amigos/Compañeros
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Redes Sociales, por favor especifique:
_______________

Curso Universitario: ______________
Otra forma: ____________________

26. ¿Cuándo se enteró del cáncer cervical, le entregaron información impresa?
Si
No
e. ¿Cuándo se enteró del cáncer cervical, fue en un lenguaje fácil de entender?
Si
No
No aplica
f. ¿Alguna pregunta que tuvo después que le otorgaron la información?
Si
No
No aplica
g. ¿Le tuvo confianza a la organización que le otorgo la información?
Si
No
No aplica
h. ¿Cree que la información que se le otorgo es auténtica?
Si
No
No aplica
27. ¿Usted cree entender que es lo que contribuye a el cáncer cervical?
Si
No
b. ¿Qué es lo que usted cree, contribuye a el cáncer cervical?

28. ¿Se ha hecho estudios para el cáncer cervical?
Si
No
¿Porque
no?_________________________________________________________________
____
b. ¿Cuál fue el ultimo ano en que se izó estudios para el cáncer cervical? ______________
Sección 3: Historial de Vacunas
Marque todas las vacunas que recibió y proporcione las fechas adecuadas.
Tipo De Vacuna:
Si
No No
Ultimo
Se
Ano
recibido
Influenza (Gripa)
Virus del papiloma humano
Neumonía
Hepatitis A
Hepatitis B
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Sección 4: Antecedentes familiares de enfermedad - Indique qué afecciones médicas se han
diagnosticado médicamente en su familia.
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Cervical Cancer Literacy Assessment Toolc
Awareness
1. Although there are many different names for types of cancers you can get them
the same way.
_____ (1) True
_____ (0) False
2. Cervical Cancer is preventable.
_____ (1) True
______ (0) False
3. Cervical Cancer is a slow growing cancer.
_____ (1) True
______ (0) False
4. Cervical Cancer does not have symptoms you can feel.
_____ (1) True
______ (0) False

Knowledge and Screening
5. A woman should begin to have a Pap test after she becomes sexually active or
when she turns 21, which ever comes first.
_______ (1) True
_____ (0) False
6. A woman should get a Pap test every three years if her previous results were
normal.
_______ (1) True
_____ (0) False
7. If a woman had a Pap test in the past with results that were abnormal, she does
not need to continue getting regular Pap tests
_______ (1) True
_____ (0) False
8. A pelvic exam is just another word for a Pap test?
_____ (1) True
_____ (2) False
9. A woman is at risk for getting cervical cancer if she has unprotected sexual
intercourse.
_______ (1) True
_____ (0) False
10. I should request a Pap test from my healthcare provider if I have:
1. Bleeding after intercourse
2. Bleeding between periods
3. Bleeding after menopause
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4. All of the above
5. None of the above
11. I should request a Pap test if:
1. I have a discharge with an odor.
2. I have pain in my pelvic area.
3. I have painful sexual intercourse.
4. I have discomfort, back-pain or poor health.
5. All of the above.
6. None of the above.
Prevention and Control
12. Using condoms decreases a woman chance for getting HPV infection that is
the main risk factor for cervical cancer.
_______ (1) True
_____ (0) False
13. Precancerous changes and early cancers of the cervix generally do not cause
pain.
_______ (1) True
_____ (0) False
14. When detected early, cervical cancer can be cured.
_______ (1) True

_____ (0) False

15. There are resources in my community for low and no cost cervical cancer
screenings.
_____ (1) True _______ (0) False
16. If my family member has cancer I am at higher risk for Cervical Cancer.
_____ (1) True
______ (0) False
17. Getting a Pap test is very painful.
_____ (1) True
______ (0) False
18. Women who do not have sexual intercourse do not need to get a Pap test.
_____ (1) True
______ (0) False
19. Pap tests are for women in childbearing years, older women do not need it.
_____ (1) True
______ (0) False
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20. The following are risk factors for Cervical Cancer:
1. Giving birth to many children
2. Having many sexual partners
3. Having sex with a partner who has many partners
4. Having a weak immune system
5. All of the above
6. None of the above
21. Recovery from cervical cancer depends on
1. The stage of cancer
2. The type of cancer
3. The size of the cancer
4. All of the above
5. None of the above
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Cervical Cancer Literacy Assessment Toolc
Conciencia
1. Si bien hay varios diferentes nombres para cada tipo de cáncer los puedes contraer
todos de la misma forma.
_____ (1) Verdadero

_____ (0) Falso

2. El cáncer de cuello uterino es prevenible.
_____ (1) Verdadero

_____ (0) Falso

3. El cáncer de cuello uterino es un cáncer de crecimiento lento.
_____ (1) Verdadero

_____ (0) Falso

4. El cáncer de cuello uterino no tiene síntomas que usted puedas sentir.
_____ (1) Verdadero

_____ (0) Falso

Conocimiento y Cernimiento o Tamizado
5. Una mujer debería empezar a tener una prueba de pap después que se haga
sexualmente activa o cuando cumpla 21, cualquiera que ocurra primero.
_____ (1) Verdadero

_____ (0) Falso

6. Una mujer debería realizar una prueba de pap cada tres años si sus previos
resultados fueron normales.
_____ (1) Verdadero

_____ (0) Falso

7. Si una mujer tuvo una prueba de pap en el pasado con resultados que fueron
anormales, ella no necesita continuar realizando pruebas de pap regularmente
_____ (1) Verdadero

_____ (0) Falso

8. ¿Un examen pélvico es solo otra palabra para una prueba de pap?
_____ (1) Verdadero

_____ (0) Falso
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9. Una mujer se encuentra en riesgo de contraer cáncer del cuello uterino si ella tiene
una relación sexual sin protección.
_____ (1) Verdadero

_____ (0) Falso

10. Yo debería solicitar una prueba de pap a mi proveedor de cuidado de salud si yo
tengo:
6. Sangrados después de la relación sexual
7. Sangrado entre periodos
8. Sangrado después de la menopausia
9. Todos los de arriba
10. Ninguno de los de arriba
11. Yo debería solicitar una prueba de pap si:
7. Yo tengo flujos con olor.
8. Yo tengo dolor en el área de mi pelvis.
9. Yo tengo relaciones sexuales dolorosas.
10. Yo tengo malestar, dolor de espalda o mala salud.
11. Todos los de arriba
12. Ninguno de los de arriba.
Prevención y Control
12. Usar condones decrece las posibilidades de una mujer de contraer la infección por
el VPH el cual es el principal factor de riesgo del cáncer del cuello uterino.
_____ (1) Verdadero
_____ (0) Falso
13. Cambios pre cancerígenos y cánceres tempranos de la cérvix generalmente no
causan dolor.
_____ (1) Verdadero

_____ (0) Falso

14. Cuando se detecta temprano, el cáncer del cuello uterino puede ser curado.
_____ (1) Verdadero

_____ (0) Falso

15. Hay recursos en mi comunidad para realizar cernimiento o tamizado de cáncer del
cuello uterino a bajo o no costo.
_____ (1) Verdadero

_____ (0) Falso

16. Si un miembro de mi familia tienen cáncer yo tengo altos riesgos de tener cáncer
del cuello uterino.
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_____ (1) Verdadero

_____ (0) Falso

17. Realizar una prueba de pap es muy dolorosa.
_____ (1) Verdadero

_____ (0) Falso

18. Las mujeres que no tienen relaciones sexuales no necesitan hacer una prueba de
pap.
_____ (1) Verdadero
_____ (0) Falso
19. Las pruebas de Pap son para mujeres en edad de concebir, mujeres mayores no lo
necesitan.
_____ (1) Verdadero

_____ (0) Falso

20. Los siguientes are factores de riesgo para el cáncer del cuello uterino:
a. Dar a luz muchos niños
b. Tener muchas parejas sexuales.
c. Tener relaciones sexuales con una pareja quien tiene muchas
parejas.
d. Tener un sistema inmune débil.
e. Todos los de arriba
f. Ninguno de los de arriba
21. Recuperarse del cáncer del cuello uterino depende de
a. La etapa del cáncer
b. El tipo de cáncer
c. El tamaño del cáncer
d. Todos los de arriba
e. Ninguno de los de arriba
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List of key/words phrases
Cervical cancer is:
• Reproductive system cancer in females (borderline correct, may need more specific
details)
• Cancer in the cervix and surrounding area
• Cancer of the cervix
• Cancer of the neck of uterus
• Cancer in your uterus (borderline correct, may need more specific details)
• Abnormal cells growing in cervix
• Fast growing cells specific to cervical region
• Cancer in lining of cervix
Risk factors for cervical cancer:
• Genetic
• Hereditary
• HPV
• Not using condoms
• Unprotected sex
• Having many sexual partners
• Multifactorial comorbidities
• Infection with STD/HIV
• Smoking
• Having many children
• The use of birth control pills longer than 5 years
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